A receding hairline is the most common presentation of androgenetic hair loss in men and the point at which most patients first seek treatment. Understanding the full range of options — from medical treatment to surgical intervention — and the evidence behind each helps patients make decisions that are right for their specific situation.
Medical treatment — finasteride and minoxidil — is typically the first-line approach for patients at early stages of recession who have not yet progressed significantly. Finasteride, in particular, is effective at stabilising temporal recession by reducing DHT, and in some patients produces meaningful hairline regrowth when started while follicles are still in the miniaturisation phase. Starting early produces better responses than starting late.
For patients in whom medical treatment has stabilised loss but cannot restore coverage that has already been lost, hair transplant surgery is the definitive restorative option. A well-planned FUE procedure addressing the temporal recession and frontal hairline typically produces results that genuinely transform appearance — the combination of a natural hairline and restored temples is among the most impactful outcomes in elective surgery.
Scalp micropigmentation (SMP) is an alternative for patients who prefer a closely cropped appearance and do not want surgery, or who want to add perceived density to a hairline that surgery has improved but not fully filled. SMP works best when the hair is worn short and the dots blend with the existing hair at the hairline.
Camouflage products — fibres, powders, sprays — are non-medical, non-surgical options that provide immediate cosmetic improvement without addressing the underlying loss. They are useful in the short term and as bridges between stages, but they are not treatments in any meaningful sense.
Related reading
